Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway

Cancer Letters

Volumn 364, Issue 2, 2015, Pages 165-172

  Shao, Nan ^a   Lu, Zhenhai ^b   Zhang, Yunjian ^a   Wang, Mian ^a   Li, Wen ^a   Hu, Ziye ^a   Wang, Shenming ^a   Lin, Ying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Breast cancer; IL 8; Integrin 3; NF B; PI3K Akt

Indexed keywords

BETA3 INTEGRIN; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VITRONECTIN RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENETICS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INTEGRIN BETA3; INTERLEUKIN-8; MCF-7 CELLS; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84930084705     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.05.009     Document Type: Article

References (22)

1. Ruiterkamp J., Ernst M.F. The role of surgery in metastatic breast cancer. Eur. J. Cancer 2011, 47:S6-S22.
2. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
3. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
4. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol 2004, 5:816-826.
5. Jin H., Varner J. Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 2004, 90:561-565.
6. dos Santos P.B., Zanetti J.S., Ribeiro-Silva A., Beltrão E.I. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study. Diagn. Pathol 2012, 7:104.
7. Bianchi-Smiraglia A., Paesante S., Bakin A.V. Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 2013, 32:3049-3058.
8. Gruber G., Hess J., Stiefel C., et al. Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. Br. J. Cancer 2005, 92:41-46.
9. Gasparini G., Brooks P.C., Biganzoli E., et al. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin. Cancer Res 1998, 4:2625-2634.
10. Ducassou A., Uro-Coste E., Verrelle P., et al. αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): prognostic factors in a phase I-II clinical trial associating continuous administration of tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma. Eur. J. Cancer 2013, 49:2161-2169.
11. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001, 12:375-391.
12. Brat D.J., Bellail A.C., Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncol 2005, 7:122-133.
13. Freund A., Chauveau C., Brouillet J.P., et al. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 2003, 22:256-265.
14. Lin Y., Huang R., Chen L., Li S., Shi Q., Jordan C., et al. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer 2004, 109:507-515.
15. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
16. Kim L.S., Huang S., Lu W., Lev D.C., Price J.E. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin. Exp. Metastasis 2004, 21:107-118.
17. Sloan E.K., Pouliot N., Stanley K.L., Chia J., Moseley J.M., Hards D.K., et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 2006, 8:R20.
18. Takayama S., Ishii S., Ikeda T., Masamura S., Doi M., Kitajima M. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res 2005, 25:79-83.
19. Lee C.Y., Huang C.Y., Chen M.Y., Lin C.Y., Hsu H.C., Tang C.H. IL-8 increases integrin expression and cell motility in human chondrosarcoma cells. J. Cell. Biochem 2011, 112:2549-2557.
20. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
21. Sheng S., Qiao M., Pardee A.B. Metastasis and AKT activation. J. Cell. Physiol 2009, 218:451-454.
22. Shrimali D., Shanmugam M.K., Kumar A.P., Zhang J., Tan B.K., Ahn K.S., et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett 2013, 341:139-149.